SCHEMBL8211769

SCHEMBL8211769

CCOC(=O)C1CCN(S(=O)(=O)N2CCOCC2)CC1.O=C(O)C1CCN(S(=O)(=O)N2CCOCC2)CC1

nearest known ligand 0.71

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.71
ALDH1A1 P00352 4/20 0.60
POLB P06746 3/20 0.60
KMT2A Q03164 2/20 0.53
MEN1 O00255 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.52
PKM P14618 2/20 0.51
NPSR1 Q6W5P4 1/20 0.51
TP53 P04637 1/20 0.49
CYP3A4 P08684 1/20 0.49
MAPK1 P28482 1/20 0.49
CYP2C19 P33261 1/20 0.49
LMNA P02545 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
TDP1 Q9NUW8 2/20 0.48
HTT P42858 2/20 0.47
KDM4E B2RXH2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6521670 0.95 ALDH1A1 (0.65) TSHRALDH1A1POLBKMT2AMEN1
SCHEMBL3183107 0.84 TSHR (1.00) TSHRALDH1A1POLBKMT2ASMN1; SMN2
SCHEMBL7119341 0.77 MAPT (0.55) TSHRALDH1A1POLBKMT2AMEN1
SCHEMBL18039877 0.76 MAPT (0.54) TSHRALDH1A1SMN1; SMN2LMNAKDM4E
SCHEMBL3019223 0.75 ALDH1A1 (0.61) TSHRALDH1A1POLBKMT2AMEN1
SCHEMBL561797 0.75 TP53 (0.67) TSHRALDH1A1POLBKMT2AMEN1
SCHEMBL1296409 0.74 PPM1B (0.55) ALDH1A1KMT2AMEN1SMN1; SMN2PKM
SCHEMBL8485910 0.74 PPM1B (0.55) ALDH1A1KMT2AMEN1SMN1; SMN2PKM
SCHEMBL29497130 0.74 TSHR (0.78) TSHRALDH1A1POLBKMT2AMEN1
SCHEMBL19123323 0.74 ALDH1A1 (0.59) TSHRALDH1A1POLBKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2475644-A1 HSL INHIBITORS USEFUL IN THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-07-18 EP disclosed
WO-2011029808-A1 HSL INHIBITORS USEFUL IN THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-03-17 WO disclosed